Ketamine for Combined Depression and Alcohol Use Disorder: A Blinded Randomized Active Placebo-controlled Trial (the KeDA Trial)
Phase: PHASE1, PHASE2 | Sponsor: University Hospital of North Norway | Compound: Ketamine
- Status
- planned
- Institution
- University Hospital of North Norway
- Start date
- 2025-01-01
- End date
- 2027-07-01
- Registry ID
- NCT06090422
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.